Form 483

North American Herb and Spice Co. LTD, LLC Form 483, 2024-05-13

FDA issued a Form 483 to North American Herb and Spice Co. LTD, LLC on 2024-05-13 with 18 public-safe observations.

483· Form 483 issuedFoods & Cosmetics18 observations

North American Herb and Spice Co. LTD, LLC · Mundelein, United States · Issued May 13, 2024

Overview

  • 18 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 May 2024
21 CFR 111.140 (b)(3)(ii)

Material review, disposition, follow-up; investigation

Cited by Alecia L Marson

13 May 2024
21 CFR 111.140 (b)(3)(ii)

Material review, disposition, follow-up; investigation

Cited by Alecia L Marson

13 May 2024
21 CFR 111.140 (b)(3)(ii)

Material review, disposition, follow-up; investigation

Cited by Alecia L Marson

13 May 2024
21 CFR 111.70(b)(2)

Specifications-component purity, strength, composition

Cited by Alecia L Marson

13 May 2024
21 CFR 111.70(b)(2)

Specifications-component purity, strength, composition

Cited by Alecia L Marson

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.140 (b)(3)(ii)Cited across public-safe Form 483 observations3x
21 CFR 111.70(b)(2)Cited across public-safe Form 483 observations3x
21 CFR 111.75(a)(2)Cited across public-safe Form 483 observations3x
21 CFR 111.75(c)Cited across public-safe Form 483 observations3x
21 CFR 117.130(a)(1)Cited across public-safe Form 483 observations3x
21 CFR 117.415(a)(1)Cited across public-safe Form 483 observations3x

Full 483 report

Get the verbatim text of all 18 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere